Are you Dr. Ayash?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4100 John R St
Karmanos Cancer Inst
Detroit, MI 48201Phone+1 800-527-6266Fax+1 313-576-8767
Summary
- Dr. Lois Ayash, MD is an oncologist in Detroit, Michigan. She is currently licensed to practice medicine in Michigan, New York, and Massachusetts. She is affiliated with Karmanos Cancer Center, DMC Harper University Hospital, and DMC Detroit Receiving Hospital & University Health Center.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1990
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1985 - 1988
St Vincent HospitalResidency, Internal Medicine, 1981 - 1984
University of Massachusetts Medical SchoolClass of 1981
Certifications & Licensure
MI State Medical License 1997 - 2026
MA State Medical License 1983 - 2025
NY State Medical License 1987 - 1998- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Start of enrollment: 2007 Jan 01
- Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma Start of enrollment: 2015 Feb 12
- Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 1 citationsHaploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis.Dipenkumar Modi, Seongho Kim, Maya Shatta, Abhinav Deol, Andrew Kin
Bone Marrow Transplantation. 2024-08-01 - 1 citationsAllogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission.Dipenkumar Modi, Samer Alkassis, Seongho Kim, Andrew Kin, Abhinav Deol
Leukemia & Lymphoma. 2023-05-08 - Role of High-Dose Adjuvant Chemotherapy Followed by Autologous Stem Cell Transplantation in Locally Advanced Triple-Negative Breast Cancer: A Retrospective Chart Review.Bayan Al-Share, Hadeel Assad, Judith Abrams, Abhinav Deol, Asif Alavi
Journal of Oncology. 2022-01-01
Press Mentions
Graduating Fellow and Karmanos Breast Cancer Specialist Co-Author Manuscript on Triple Negative Breast Cancer with BMT FacultyOctober 18th, 2022
Grant Support
- Tetrathiomolybdate As Maintenance Therapy After Autologous Peripheral Stem CellNational Center For Research Resources2004–2005
Professional Memberships
- Member
